×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
合肥物质科学研究院 [7]
上海药物研究所 [4]
近代物理研究所 [1]
内容类型
期刊论文 [12]
发表日期
2021 [12]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共12条,第1-10条
帮助
限定条件
发表日期:2021
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Silencing of the lncRNA H19 enhances sensitivity to X-ray and carbon-ions through the miR-130a-3p /WNK3 signaling axis in NSCLC cells
期刊论文
Cancer Cell International, 2021, 卷号: 21, 期号: 1, 页码: 12
作者:
Zhao,Xueshan
;
Jin,Xiaodong
;
Zhang,Qiuning
;
Liu,Ruifeng
;
Luo,Hongtao
收藏
  |  
浏览/下载:265/0
  |  
提交时间:2021/12/13
LncRNA H19
MiR-130a-3p
WNK3
Non-small-cell lung cancer
Radiotherapy
Inner nuclear membrane protein TMEM201 promotes breast cancer metastasis by positive regulating TGF beta signaling
期刊论文
ONCOGENE, 2021, 页码: 10
作者:
Kong, Ya
;
Zhang, Yutian
;
Wang, Hanlin
;
Kan, Weijuan
;
Guo, Haoran
收藏
  |  
浏览/下载:51/0
  |  
提交时间:2022/01/04
A validated HPLC-MS/MS method for determination of simmitecan and its metabolite chimmitecan in human plasma and its application to a pharmacokinetic study in Chinese patients with advanced solid tumor
期刊论文
JOURNAL OF SEPARATION SCIENCE, 2021, 页码: 8
作者:
Zhou, Jun
;
Zhan, Yan
;
Zhong, Dafang
;
Chen, Xiaoyan
;
Zhang, Yifan
收藏
  |  
浏览/下载:72/0
  |  
提交时间:2021/11/04
chimmitecan
mass spectrometry
pharmacokinetics
simmitecan
solid tumors
Pulmonary enteric adenocarcinoma
期刊论文
TRANSLATIONAL ONCOLOGY, 2021, 卷号: 14
作者:
Gong, Jiali
;
Fan, Ying
;
Lu, Hongyang
收藏
  |  
浏览/下载:54/0
  |  
提交时间:2021/11/01
PEAC
Immunohistochemistry
Mutation analysis
Diagnosis
Prognosis
Neoantigen load as a prognostic and predictive marker for stage II/III non-small cell lung cancer in Chinese patients
期刊论文
THORACIC CANCER, 2021
作者:
Gong, Lei
;
He, Ronghui
;
Xu, Yanjun
;
Luo, Taobo
;
Jin, Kaixiu
收藏
  |  
浏览/下载:38/0
  |  
提交时间:2021/08/31
biomarker
neoantigen load
NSCLC
prognosis
whole exome sequencing
KRAS-Mutant Non-Small Cell Lung Cancer: An Emerging Promisingly Treatable Subgroup
期刊论文
FRONTIERS IN ONCOLOGY, 2021, 卷号: 11
作者:
Xie, Mingying
;
Xu, Xiaoling
;
Fan, Yun
收藏
  |  
浏览/下载:45/0
  |  
提交时间:2021/06/15
KRAS-mutant
NSCLC
targeted therapy
immunotherapy
AMG510
MRTX849
Discovery of a highly potent kinase inhibitor capable of overcoming multiple imatinib-resistant ABL mutants for chronic myeloid leukemia (CML)
期刊论文
EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 卷号: 897
作者:
Lu, Tingting
;
Cao, Jiangyan
;
Zou, Fengming
;
Li, Xixiang
;
Wang, Aoli
收藏
  |  
浏览/下载:42/0
  |  
提交时间:2021/04/26
BCR-ABL
ABL mutants
Chronic myeloid leukemia
Kinase inhibitor
Imatinib resistance
Design, synthesis and pharmacological evaluation of bicyclic and tetracyclic pyridopyrimidinone analogues as new KRAS(G12C) inhibitors
期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 卷号: 213, 页码: 17
作者:
Xiao, Xuanzheng
;
Lai, Mengzhen
;
Song, Zilan
;
Geng, Meiyu
;
Ding, Jian
收藏
  |  
浏览/下载:47/0
  |  
提交时间:2021/05/24
KRAS
Covalent inhibitor
Pyridopyrimidinone
Antiproliferative effect
Scaffold hopping
Role of oncogene PIM-1 in the development and progression of papillary thyroid carcinoma: Involvement of oxidative stress
期刊论文
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2021, 卷号: 523
作者:
Wen, Qing-Liang
;
Yi, He-Qing
;
Yang, Ke
;
Yin, Chang-Tian
;
Yin, Wen-Juan
收藏
  |  
浏览/下载:25/0
  |  
提交时间:2021/03/15
Papillary thyroid carcinoma
PIM-1
Oxidative stress
NOX4
NCK1-AS1 promotes the progression of lung squamous cell carcinoma through transcriptionally upregulating NCK1 via interacting with MYC
期刊论文
CANCER BIOLOGY & THERAPY, 2021
作者:
Zhou, Xia
;
Bao, Wuan
;
Zhang, Danhong
;
Yang, Yang
;
Du, Xianghui
收藏
  |  
浏览/下载:35/0
  |  
提交时间:2021/04/26
NCK1-AS1
NCK1
LUSC
MYC
©版权所有 ©2017 CSpace - Powered by
CSpace